You're reading the free version. Trader adds the live tape and alerts.
Start tracking
RPRX Sale Disclosure
Urist Marshall · SEC Form 4 · Filed Jul 2, 2026
Sale
Calculated transaction value
$508.45K
Urist Marshall EVP, Research & Investments
RPRX
Transaction date
Jul 1, 2026
Public filing date
Jul 2, 2026
Filing lag
Filed 1 day later
RPRX daily price context
Close on/before transaction
$55.78
Jul 1, 2026
First close after public filing
$56.92
Jul 6, 2026
30-day return after filing
+0.44%
Through Aug 3, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Class A Ordinary Shares
- Quantity / price
- 9,099 shares @ $55.88
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001838139-26-000022
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$508.45K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Royalty Pharma Plc RPRX Current | Sale | Jul 1, 2026 | $508.45K |